Literature DB >> 10964545

Duffy phenotype does not influence the clinical severity of sickle cell disease.

J B Schnog1, S O Keli, R A Pieters, R A Rojer, A J Duits.   

Abstract

The red blood cell Duffy antigen receptor for chemokines serves as a sink for the clearance of chemokines such as interleukin-8 (IL-8) from the circulation. We analyzed the impact of the Duffy phenotype on sickle cell disease (SCD) severity and serum IL-8 levels in 15 Duffy-positive and 36 Duffy-negative sickle cell patients. There was no difference in clinical severity between Duffy-positive and Duffy-negative sickle cell patients. In asymptomatic sickle cell patients the upward deviation of mean serum IL-8 levels was significantly greater in Duffy-negatives (n = 20) than in Duffy-positives (n = 8) (P = 0.011). However, during a vasoocclusive episode, serum IL-8 levels were similar between Duffy-negatives (n = 11) and Duffy-positives (n = 3). Although the Duffy phenotype seems to influence steady-state serum IL-8 levels, it does not seem to have an effect on SCD severity. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10964545     DOI: 10.1006/clim.2000.4884

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  3 in total

1.  Activation state of alpha4beta1 integrin on sickle red blood cells is linked to the duffy antigen receptor for chemokines (DARC) expression.

Authors:  Marie-Claude Durpès; Marie-Dominique Hardy-Dessources; Wassim El Nemer; Julien Picot; Nathalie Lemonne; Jacques Elion; Monique Decastel
Journal:  J Biol Chem       Date:  2010-11-18       Impact factor: 5.157

Review 2.  DARC and D6: silent partners in chemokine regulation?

Authors:  Chris A H Hansell; Catherine E Hurson; Robert J B Nibbs
Journal:  Immunol Cell Biol       Date:  2010-12-14       Impact factor: 5.126

3.  The effect of Duffy antigen receptor for chemokines on severity in sickle cell disease.

Authors:  Emma R Drasar; Stephan Menzel; Tony Fulford; Swee Lay Thein
Journal:  Haematologica       Date:  2013-06-10       Impact factor: 9.941

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.